News

New advances in brain-computer interface (BCI) technology may make speech for those who've lost the ability to do easier than ...
By decoding neural signals linked to a person’s inner monologue, researchers enabled communication for individuals with ...
Long-term exposure to sulfur dioxide, an air pollutant generated by the burning of fossil fuels, increases the risk of ALS, a ...
A Jacksonville woman's experience caring for her husband with ALS has formed a foundation to help other families fighting terminal illness.
Brooke Eby posted a "dying diary" to describe the feeling of her ALS and progressing paralysis. The 36-year-old TikToker ...
Medically reviewed by Nicholas R. Metrus, MD Multiple sclerosis (MS) and amyotrophic lateral sclerosis (ALS, also called Lou Gehrig's disease) are both diseases that affect your central nervous system ...
In the beginning, not even Hynek Wichterle's postdoc thought his idea to slow the progression of amyotrophic lateral ...
Amyotrophic lateral sclerosis (ALS) is a life-threatening neurodegenerative disorder with a two- to three-year median survival after the appearance of symptoms. ALS mainly affects upper and lower ...
• Key Amyotrophic Lateral Sclerosis Pipeline Therapies: ION363, FB418, SRK-015, RNS60, QRL-201, SAR443820, MN-166, VM202, VRG-50635, Zilucoplan, and others.
Amyotrophic lateral sclerosis (ALS) is the most common motor neuron disease, with an incidence of 1 or 2 cases per 100,000 persons and a lifetime risk of 1 case per 800 persons.